Pirincs Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-07-2024
- Paid Up Capital ₹ 0.33 M
as on 10-07-2024
- Company Age 9 Year, 3 Days
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2017)
- Profit -706.24%
(FY 2017)
- Ebitda -566.69%
(FY 2017)
- Net Worth -1686.87%
(FY 2017)
- Total Assets 30471.69%
(FY 2017)
About Pirincs Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.33 M, as per Ministry of Corporate Affairs (MCA) records.
Shivamkar Misra, Balraj Misra, Purti Misra, and One other member serve as directors at the Company.
- CIN/LLPIN
U33111UP2015PTC075199
- Company No.
075199
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Dec 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pirincs Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shivamkar Misra  | Director | 21-Dec-2015 | Current |
| Balraj Misra | Director | 21-Dec-2015 | Current |
| Purti Misra | Director | 21-Dec-2015 | Current |
| Shubhamkar Mishra | Director | 21-Dec-2015 | Current |
Financial Performance of Pirincs Pharmaceuticals.
Pirincs Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 706.24% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1686.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pirincs Pharmaceuticals?
In 2017, Pirincs Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Elephanta Construction Co. Private LimitedActive 20 years 9 monthsShivamkar Misra, Balraj Misra and 2 more are mutual person
- Grihasti Enterprises Private LimitedActive 9 years 11 months
Shivamkar Misra, Balraj Misra and 2 more are mutual person
- Mohammdi Healthcare Systems Private LimitedActive 19 years 7 months
Shivamkar Misra, Balraj Misra and 2 more are mutual person
- Medivisa Diagnostics Centre Private LimitedActive 7 years 3 months
Shivamkar Misra, Balraj Misra and 2 more are mutual person
- Missre Infraprojects India Private LimitedActive 9 years 9 months
Shivamkar Misra and Shubhamkar Mishra are mutual person
- Missre Pharmaceutical Private LimitedActive 9 years 2 months
Shivamkar Misra and Shubhamkar Mishra are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pirincs Pharmaceuticals?
Unlock and access historical data on people associated with Pirincs Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pirincs Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pirincs Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
